- Senseonics Holdings, Inc. Provides Business Update and Full Year 2024 Financial Outlook
- Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association’s 84th Scientific Sessions
- Senseonics Holdings, Inc. to Participate in the Sidoti Small Cap Conference
- Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results
- Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management
- Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution
- Senseonics Holdings, Inc. to Participate in Upcoming Conferences
- Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time
- Eversense® CGM System Receives iCGM Designation by the US FDA
More ▼
Key statistics
As of last trade, Senseonics Holdings Inc (SENS:ASQ) traded at 0.4643, 27.21% above the 52 week low of 0.365 set on Jun 18, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.46 |
---|---|
High | 0.47 |
Low | 0.4504 |
Bid | 0.4643 |
Offer | 0.4644 |
Previous close | 0.4608 |
Average volume | 1.21m |
---|---|
Shares outstanding | 530.89m |
Free float | 493.02m |
P/E (TTM) | -- |
Market cap | 244.63m USD |
EPS (TTM) | -0.1354 USD |
Data delayed at least 15 minutes, as of Jul 25 2024 20:42 BST.
More ▼